PNC Financial Services Group’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-10
| Closed | – | – | 4400 |
|
|
2017
Q2 | $0 | Buy |
+10
| New | – | ﹤0.01% | 4355 |
|
|
2016
Q3 | – | Sell |
-86
| Closed | – | – | 4682 |
|
|
2016
Q2 | $0 | Sell |
86
-3
| -3% | – | ﹤0.01% | 4729 |
|
|
2016
Q1 | $1K | Buy |
89
+3
| +3% | +$34 | ﹤0.01% | 4480 |
|
|
2015
Q4 | $1K | Sell |
86
-254
| -75% | -$2.95K | ﹤0.01% | 4437 |
|
|
2015
Q3 | $7K | Buy |
340
+3
| +0.9% | +$62 | ﹤0.01% | 3868 |
|
|
2015
Q2 | $17K | Buy |
337
+57
| +20% | +$2.88K | ﹤0.01% | 3585 |
|
|
2015
Q1 | $22K | Buy |
280
+11
| +4% | +$864 | ﹤0.01% | 3476 |
|
|
2014
Q4 | $16K | Hold |
269
| – | – | ﹤0.01% | 3240 |
|
|
2014
Q3 | $11K | Hold |
269
| – | – | ﹤0.01% | 3267 |
|
|
2014
Q2 | $17K | Hold |
269
| – | – | ﹤0.01% | 2997 |
|
|
2014
Q1 | $17K | Buy |
269
+34
| +14% | +$2.15K | ﹤0.01% | 2910 |
|
|
2013
Q4 | $13K | Hold |
235
| – | – | ﹤0.01% | 2933 |
|
|
2013
Q3 | $14K | Hold |
235
| – | – | ﹤0.01% | 3084 |
|
|
2013
Q2 | $14K | Buy |
+235
| New | +$14K | ﹤0.01% | 2961 |
|